1 |
Cho YC., Kim YR, Kim BR and Cho S (2016) Thunbergia alata inhibits inflammatory responses through the inactivation of ERK and STAT3 in macrophages. Int J Mol Med 38, 1596-1604
DOI
|
2 |
Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Sci 294, 1871-1875
DOI
|
3 |
Feghali CA and Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2, d12-d26
|
4 |
Ma P, Liu HT., Wei P et al (2011) Chitosan oligosaccharides inhibit LPS-induced over-expression of IL-6 and TNF- in RAW264. 7 macrophage cells through blockade of mitogen-activated protein kinase (MAPK) and PI3K/Akt signaling pathways. Carbohydr Polym 84, 1391-1398
DOI
|
5 |
Karin M, Liu Zg and Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9, 240-246
DOI
|
6 |
Kwak HJ, Song JS, Heo JY, Yang SD, Nam JY and Cheon HG (2005) Roflumilast inhibits lipopolysaccharideinduced inflammatory mediators via suppression of nuclear factor- , p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation. J Pharmacol Exp Ther 315, 1188-1195
DOI
|
7 |
Lee J, Tae N, Lee JJ, Kim T and Lee JH (2010) Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264. 7 cells by inducing proteasomal degradation of TRAF6. Eur J Pharmacol 636, 173-180
DOI
|
8 |
Finco TS, Beg AA and Baldwin AS (1994) Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl Acad Sci U S A 91, 11884-11888
DOI
|
9 |
Plotnikov A, Zehorai E, Procaccia S and Seger R (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813, 1619-1633
DOI
|
10 |
Wu LC, Fan NC, Lin MH et al (2008) Anti- inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators. J Agric Food Chem 56, 2341-2349
DOI
|
11 |
Libby P (2007) Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65, S140-S146
DOI
|
12 |
Thompson LA and Ellman JA (1996) Synthesis and applications of small molecule libraries. Chem Rev 96, 555-600
DOI
|
13 |
Barton GM and Medzhitov R (2003) Toll-like receptor signaling pathways. Science 300, 1524-1525
DOI
|
14 |
Ordureau A, Smith H, Windheim M et al (2008) The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem J 409, 43-52
DOI
|
15 |
Avila M and Gonzalez-Espinosa C (2011) Signaling through Toll-like receptor 4 and mast cell-dependent innate immunity responses. IUBMB Life 63, 873-880
DOI
|
16 |
Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K and Li X (2002) Interleukin-1 (IL-1) receptor-associated kinasedependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol 22, 7158-7167
DOI
|
17 |
Schreiber SL (1998) Chemical genetics resulting from a passion for synthetic organic chemistry. Biorg Med Chem 6, 1127-1152
DOI
|
18 |
Chen W, Wang J, Luo Y et al (2016) Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue. J Ginseng Res 40, 351-358
DOI
|
19 |
Cha BJ, Park JH, Shrestha S et al (2015) Glycosyl glycerides from hydroponic Panax ginseng inhibited NO production in lipopolysaccharide-stimulated RAW264. 7 cells. J Ginseng Res 39, 162-168
DOI
|
20 |
Kim E, Yang WS, Kim JH et al (2014) Lancemaside A from Codonopsis lanceolata modulates the inflammatory responses mediated by monocytes and macrophages. Mediators Inflamm 2014, 405158-405158
|
21 |
Nowarski R, Gagliani N, Huber S and Flavell RA (2013) Innate immune cells in inflammation and cancer. Cancer Immunol Res 1, 77-84
DOI
|
22 |
Kumar S, Bawa S and Gupta H (2009) Biological activities of quinoline derivatives. Mini Rev Med Chem 9, 1648-1654
DOI
|
23 |
Smolen JS and Maini RN (2006) Interleukin-6: a new therapeutic target. Arthrit Res Ther 8, S5
DOI
|
24 |
Emery P, Keystone E, Tony H et al (2008) IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 67, 1516-1523
DOI
|
25 |
Solomon VR and Lee H (2011) Quinoline as a privileged scaffold in cancer drug discovery. Curr Med Chem 18, 1488-1508
DOI
|
26 |
Dinarello CA (2010) Anti-inflammatory agents: present and future. Cell 140, 935-950
DOI
|
27 |
Palladino MA, Bahjat FR, Theodorakis EA and Moldawer LL (2003) Anti-TNF- therapies: the next generation. Nature Reviews Drug Discovery 2, 736-742
DOI
|
28 |
Kim SJ, Cha JY, Kang HS et al (2016) Corosolic acid ameliorates acute inflammation through inhibition of IRAK-1 phosphorylation in macrophages. BMB Rep 49, 276-281
DOI
|
29 |
Li M, Yu D, Ni B and Hao F (2017) Interleukin-1 receptor associated kinase 1 is a potential therapeutic target of anti-inflammatory therapy for systemic lupus erythematosus. Mol Immunol 87, 94-101
DOI
|
30 |
Nishimoto N (2006) Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol 18, 277-281
DOI
|
31 |
Abadi AH, Hegazy GH and El-Zaher AA (2005) Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents. Biorg Med Chem 13, 5759-5765
DOI
|
32 |
Anestakis D, Petanidis S, Kalyvas S et al (2015) Mechanisms and applications of interleukins in cancer immunotherapy. Int J Mol Sci 16, 1691-1710
DOI
|
33 |
Scheidt-Nave C, Bismar H, Leidig-Bruckner G et al (2001) Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 86, 2032-2042
|
34 |
Neu HC (1992) Quinolone antimicrobial agents. Annu Rev Med 43, 465-486
DOI
|